Chemotherapy-Induced Peripheral Neuropathy: What Actually Helps Years Later
Numbness, burning, and balance loss after taxanes, platinums, or vinca alkaloids can persist for years. What the evidence supports, what to stop trying, and when the balance risk becomes the bigger problem.
Chemotherapy-induced peripheral neuropathy (CIPN) is the late effect survivors most often describe as invisible. It rarely shows on a routine exam, it is easy to attribute to age, and it is one of the strongest predictors of falls in long-term survivors.
Which exposures make CIPN likely
Ask for the agent and the cumulative dose, not just the regimen name. Taxanes and platinums account for the majority of persistent cases, and risk rises with cumulative exposure, pre-existing diabetes, and baseline neuropathy from any cause.
Timing matters for interpretation. Platinum neuropathy can worsen for months after the final dose, a pattern called coasting, so a symptom that started after treatment ended is not evidence against a treatment cause.
What the evidence supports
For painful CIPN, duloxetine is the intervention with the most consistent trial support in major guidance, and it is the reasonable first pharmacologic trial when pain is the dominant complaint. Response is partial for most people, so set that expectation before starting.
For numbness, balance loss, and function, drugs are not the answer. Structured exercise and balance-focused physical therapy have the better evidence for what survivors actually want back: stable walking, confident stairs, and grip.
Many widely marketed supplements have been studied and have not shown consistent benefit. Spending money on them is a common and avoidable cost.
The risk that outranks the symptom
Falls are the outcome that changes lives. If sensation loss is present, screen gait and balance, review home hazards, check vitamin B12 and thyroid, and reconcile every medication that adds sedation or orthostasis.
In survivors with bone-density loss from aromatase inhibitors, androgen deprivation, steroids, or transplant, a neuropathy-related fall becomes a fracture question. The two late effects should be assessed together, not in separate visits.
Frequently asked questions
- Does chemotherapy neuropathy ever go away completely?
- Some people recover fully within the first year or two. A substantial minority have persistent symptoms, and platinum-related symptoms can worsen for months after the final dose before stabilizing.
- Do supplements help chemotherapy neuropathy?
- Most commonly marketed supplements have not shown consistent benefit in trials. Discuss any supplement with your clinician, particularly if you take anticoagulants or endocrine therapy.